{"id":"W3169849224","doi":"10.1016/s1470-2045(21)00216-3","title":"Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eisai; Array BioPharma; Clovis Oncology; Roche; Mersana Therapeutics; Novartis; Merck KGaA; Merck; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Javelin; Ovarian cancer; Avelumab; Medicine; Refractory (planetary science); Chemotherapy; Open label; Oncology; Internal medicine; Cancer; Clinical trial; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001588135,0.0005249854,0.002032604,0.0001865116,0.0001802771,0.00010214,0.0005151284,0.0002742322,0.00320752],"category_scores_gemma":[0.0001436495,0.0003220331,0.00004520121,0.0009639067,0.0001633264,0.0002523097,0.0001048138,0.000672015,0.00001423133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001559792,"about_ca_system_score_gemma":0.002359773,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004880454,"about_ca_topic_score_gemma":0.1227414,"domain_scores_codex":[0.9961086,0.0007707551,0.0009283439,0.0009422249,0.0004915571,0.0007585562],"domain_scores_gemma":[0.9971265,0.0009362865,0.0004638111,0.001066409,0.0002047931,0.0002021561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7939706,0.0584125,0.01650042,0.00009519979,0.001735534,0.004813311,0.007824589,0.00007163743,0.002941887,0.0003809397,0.001750649,0.1115028],"study_design_scores_gemma":[0.872629,0.03167801,0.07978816,0.0003401617,0.0003803311,0.00009728161,0.001696145,0.0008888618,0.0009990536,0.0001603448,0.01081948,0.0005231928],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683591,0.0005811807,0.00009735204,0.0231225,0.000468897,0.005679166,0.0000947981,0.00007314442,0.001523874],"genre_scores_gemma":[0.9876137,0.001310349,0.003365078,0.004176298,0.000562222,0.002070315,0.0001709315,0.0001185103,0.0006125389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1178609,"threshold_uncertainty_score":0.9999232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09341405805658175,"score_gpt":0.4002533787875807,"score_spread":0.3068393207309989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}